Has Andrew Rosenbaum, MD received payments from drug or device companies?

Yes. Drug and device makers reported $466,506 in general payments to Andrew Rosenbaum, MD across 422 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Rosenbaum, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Rosenbaum, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Rosenbaum, MD

Orthopaedic Surgery · Albany, NYNPI 1487979803

Payments from drug & device makers

$466,506in general payments, 2019–2025

Across 422 payments — averaging $1105.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$452K
Prodigy Surgical Distribution, Inc.$11K
Gotham Surgical Solutions & Devices, Inc.$1K
Stryker$698
Treace Medical Concepts, Inc.$585
Johnson & Johnson$188
plus $559 from 8 others

$319in research payments, 2019–2025

Across 1 payment — averaging $318.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$319

What the payments were for

Consulting fees$94,14920%
Speaking & faculty fees$315,26268%
Travel & lodging$44,82410%
Food & beverage$7,6432%
Education$4,6281%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	367	$452,324
Prodigy Surgical Distribution, Inc.	26	$10,951
Gotham Surgical Solutions & Devices, Inc.	1	$1,200
Stryker	8	$698
Treace Medical Concepts, Inc.	8	$585
Johnson & Johnson(2 entities)	2	$188
Flower Orthopedics Coporation	1	$159
Solventum Corporation	1	$135
Mid-atlantic Surgical Systems, LLC	1	$109
Abbott	1	$53
Smith+Nephew	3	$52
AbbVie	1	$19
Mimedx Group, Inc.	1	$16
Vertex	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$22,692
DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE EXTERNAL FIXATION$5,625
DISTAL EXTREMITIES IMPLANTS TRAUMA ANKLE FRACTURE$1,125
DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ANCHORS$750
DISTAL EXTREMITIES IMPLANTS FOREFOOT PLANTAR PLATE$375
DISTAL EXTREMITIES IMPLANTS FRACTURE MANAGEMENT ANKLE FRACTURE$221
TMC SPEEDMTP$215
DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS MIDFOOT SCREWS$188
Lapiplasty$172
INCOMPASS TOTAL ANKLE SYSTEM$161
VARIAX$154
DISTAL EXTREMITIES IMPLANTS TRAUMA MINI FRAGMENT$138
V.A.C. GRANUFOAM$135
EASYFUSE$134
DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE BUNION$126
DISTAL EXTREMITIES INSTRUMENTS PERCUTANEOUS FOOT SURGERY SU BURRS$114
MINIBUNION$101
FIBERGRAFT Aeridyan Matrix$101

How this compares

$466,506 in reported general payments places this provider in the 90th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$213,771

Medicare patients

293

Services billed

1,613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	61	$975
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	76	$866
Gabapentin	55	$604
Oxycodone Hcl	76	$530
Tramadol Hcl	87	$398
Meloxicam	66	$252
Pregabalin	14	$247
Ibuprofen	32	$199
Diclofenac Sodium	29	$173
Doxycycline Hyclate	15	$124
Ondansetron OdtOndansetron	16	$111
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	16	$106
Naproxen	20	$82

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Albany

Anthony RomeoNew York$27M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$14.1M
William RicciNew York$11.6M
Steven HaasNew York$11.5M
Giles ScuderiNew York$10.9M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →